Most cited papers in Urinary and Genital Oncology Studies
What are the most cited papers in Urinary and Genital Oncology Studies?
The most cited paper in Urinary and Genital Oncology Studies is "TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells" (Sanjeev Mariathasan et al., 2018), with 5,718 citations. Next come "Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients" (3,563) and "The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours" (3,191).
Showing 50 of 100 papers. Every paper with more than 512 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells Sanjeev Mariathasan et al. · Nature | Feb 2018 | 5,718 |
| 2 | Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients John P. Stein, Gary Lieskovsky, Rick Cote et al. · Journal of Clinical Oncology | Feb 2001 | 3,563 |
| 3 | The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours Holger Moch, Antonio L. Cubilla, Peter A. Humphrey et al. · European Urology | 28 Feb 2016 | 3,191 |
| 4 | Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer Herbert Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al. · New England Journal of Medicine | 27 Aug 2003 | 2,691 |
| 5 | Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends Sébastien Antoni, Jacques Ferlay, Isabelle Soerjomataram et al. · European Urology | 29 Jun 2016 | 2,669 |
| 6 | Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study Hans von der Maase, Steen Werner Hansen, James T. Roberts et al. · Journal of Clinical Oncology | 17 Sep 2000 | 2,312 |
| 7 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 Marko M. Babjuk, Andreas Böhle, Maximilian Burger et al. · European Urology | 20 Jun 2016 | 2,308 |
| 8 | European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines Johannes Alfred Witjes, Harman Max Bruins, Richard L. Cathomas et al. · European Urology | 29 Apr 2020 | 2,175 |
| 9 | Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer Hans von der Maase, Lisa Sengeløv, James T. Roberts et al. · Journal of Clinical Oncology | 20 Jul 2005 | 1,870 |
| 10 | Bladder Cancer Andrew Thomas Lenis, Patrick M. Lec, Karim Chamie et al. · JAMA | 17 Nov 2020 | 1,849 |
| 11 | Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors Álvaro Morales, David Eidinger, Andrew W. Bruce · The Journal of Urology | Aug 1976 | 1,803 |
| 12 | Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy Woonyoung Choi, Sima P. Porten, Seungchan Kim et al. · Cancer Cell | Feb 2014 | 1,778 |
| 13 | European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) Marko M. Babjuk, Maximilian Burger, Otakar Čapoun et al. · European Urology | 9 Sep 2021 | 1,707 |
| 14 | The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder Jonathan I. Epstein, Mahul B. Amin, Victor R. Reuter et al. · The American Journal of Surgical Pathology | Dec 1998 | 1,595 |
| 15 | Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer Johannes Alfred Witjes, Thierry Lebrét, Éva Compérat et al. · European Urology | 2 Jul 2016 | 1,521 |
| 16 | Bladder cancer Ashish M. Kamat, Noah M. Hahn, Jason Alexander Efstathiou et al. · The Lancet | 25 Jun 2016 | 1,477 |
| 17 | Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology Ahmad Shabsigh, Ruslan Korets, Kinjal C. Vora et al. · European Urology | 19 Jul 2008 | 1,414 |
| 18 | Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline Sam S. Chang, Stephen Anthony Boorjian, Roger Chou et al. · The Journal of Urology | 20 Jun 2016 | 1,406 |
| 19 | Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma Yohann Loriot et al. · New England Journal of Medicine | 24 Jul 2019 | 1,396 |
| 20 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update Morgan Rouprêt, Marko M. Babjuk, Éva Compérat et al. · European Urology | 16 Jul 2015 | 1,346 |
| 21 | European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update Marko M. Babjuk, Maximilian Burger, Éva Compérat et al. · European Urology | 20 Aug 2019 | 1,344 |
| 22 | Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data Claire Louise Vale · European Urology | 22 Apr 2005 | 1,326 |
| 23 | Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials Richard J Sylvester, Adrian P.M. van der Meijden, Donald L. Lamm · The Journal of Urology | Nov 2002 | 1,318 |
| 24 | Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity Margaret A. Knowles, Carolyn D. Hurst · Nature reviews. Cancer | 23 Dec 2014 | 1,294 |
| 25 | Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma Thomas B. Powles, Jonathan E. Rosenberg, Guru Sonpavde et al. · New England Journal of Medicine | 12 Feb 2021 | 1,233 |
| 26 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 Marko M. Babjuk, Maximilian Burger, Richard E. Zigeuner et al. · European Urology | 12 Jun 2013 | 1,180 |
| 27 | Association Between Smoking and Risk of Bladder Cancer Among Men and Women Neal D. Freedman · JAMA | 16 Aug 2011 | 1,170 |
| 28 | Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration Vitaly Margulis, Shahrokh François Shariat, Surena F. Matin et al. · Cancer | 20 Jan 2009 | 1,149 |
| 29 | Treatment of muscle‐invasive and advanced bladder cancer in 2020 Vaibhav G. Patel, William K. Oh, Matthew D. Galsky · CA A Cancer Journal for Clinicians | 7 Aug 2020 | 1,148 |
| 30 | Bladder cancer: Epidemiology, staging and grading, and diagnosis Ziya Kırkalı, Theresa Chan, Murugesan Manoharan et al. · Urology | Dec 2005 | 1,093 |
| 31 | EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update Marko M. Babjuk, Willem Oosterlinck, Richard J Sylvester et al. · European Urology | 12 Apr 2011 | 1,073 |
| 32 | Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer Thomas B. Powles et al. · New England Journal of Medicine | 6 Mar 2024 | 1,072 |
| 33 | The global burden of urinary bladder cancer: an update Anke Richters, Katja K.H. Aben, Lambertus A.L.M. Kiemeney · World Journal of Urology | Nov 2019 | 1,043 |
| 34 | A Molecular Taxonomy for Urothelial Carcinoma Gottfrid Sjödahl, Martin Lauss, Kristina Lövgren et al. · Clinical Cancer Research | 2 May 2012 | 1,016 |
| 35 | EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines Johannes Alfred Witjes, Éva Compérat, Nigel C. Cowan et al. · European Urology | 12 Dec 2013 | 1,014 |
| 36 | Bladder cancer Donald S. Kaufman, William U. Shipley, Adam Scott Feldman · The Lancet | 11 Jun 2009 | 1,005 |
| 37 | A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Patrick J. Loehrer, Lawrence H. Einhorn, Paul J. Elson et al. · Journal of Clinical Oncology | Jul 1992 | 990 |
| 38 | Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer Nicholas David James, Syed A. Hussain, Emma Hall et al. · New England Journal of Medicine | 18 Apr 2012 | 964 |
| 39 | Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline Sam S. Chang, Bernard H. Bochner, Roger Chou et al. · The Journal of Urology | 26 Apr 2017 | 955 |
| 40 | International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial International Collaboration of Trialists on behalf of the Medical Research Counc · Journal of Clinical Oncology | 19 Apr 2011 | 955 |
| 41 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update Morgan Rouprêt, Marko M. Babjuk, Maximilian Burger et al. · European Urology | 24 Jun 2020 | 951 |
| 42 | Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race Lynn M. Marshall · Obstetrics and Gynecology | Dec 1997 | 908 |
| 43 | The health economics of bladder cancer Marc F Botteman, Chris Leo Pashos, Alberto Cesare Luigi Redaelli et al. · PharmacoEconomics | Dec 2003 | 889 |
| 44 | Epidemiology of Bladder Cancer Kalyan Saginala, Adam A. Barsouk, John Sukumar Aluru et al. · Medical Sciences | 13 Mar 2020 | 850 |
| 45 | Bladder cancer Öner Şanlı, Jakub Tomasz Dobruch, Margaret A. Knowles et al. · Nature Reviews Disease Primers | 12 Apr 2017 | 841 |
| 46 | Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update M. Craig Hall, Sam S. Chang, Guido M. Dalbagni et al. · The Journal of Urology | 10 Nov 2007 | 840 |
| 47 | Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales et al. · The Journal of Urology | Mar 1992 | 799 |
| 48 | Epidemiology and outcome assessment of pelvic organ prolapse Matthew D. Barber, CHRISTOPHER F. MAHER · International Urogynecology Journal | 18 Oct 2013 | 777 |
| 49 | Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy Bas W.G. van Rhijn, Maximilian Burger, Yair Lotan et al. · European Urology | 27 Jun 2009 | 772 |
| 50 | The role of IL-10 in crossregulation of TH1 and TH2 responses Tim R. Mosmann, Kevin W. Moore · Immunology Today | 1991 | 770 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.